Difference between revisions of "HIV-1 aspartyl protease (TG2)"
m |
|||
| Line 2: | Line 2: | ||
! {{infobox header}}| '''{{PAGENAME}}''' | ! {{infobox header}}| '''{{PAGENAME}}''' | ||
|- | |- | ||
| − | | align="center" colspan="2" bgcolor="#ffffff" | [[Image: | + | | align="center" colspan="2" bgcolor="#ffffff" | [[Image:HIV-1 aspartyl protease.png|200px|{{PAGENAME}}]] |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| − | | | + | | HIV-1 aspartyl protease |
|- | |- | ||
| Synonyms | | Synonyms | ||
Revision as of 15:18, 17 August 2007
| Template:Infobox header| HIV-1 aspartyl protease (TG2) | |
|---|---|
| HIV-1 aspartyl protease (TG2) | |
| Substrate peptide name | HIV-1 aspartyl protease |
| Synonyms | - |
| Determination type | In vitro |
| Source | HIV |
| Subcellular localization | HIV |
| Swissprot ID | P04585 |
| Reactive glutamines | Not determined yet |
| Reactive lysines | Not determined yet |
| Substrate sequence | |
| Structure | 1A30 |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:1358064 |
| Notes | |
| Template:Infobox header | | |
